VRCA
Companies
NASDAQ
Verrica Pharmaceuticals Inc.
Health Care
$0.58
-$0.12 (-17.31%)
Price Chart
Overview
About VRCA
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Market Cap
$347.0M
Volume
322.2K
Avg. Volume
313.1K
P/E Ratio
-0.98203397
Dividend Yield
0.00%
Employees
65.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.13
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VRCA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$347.0M
Volume322.2K
P/E Ratio-0.98
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 12, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025